$SGXP Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in SGX PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in SGX PHARMACEUTICALS, INC.. Get notifications about new insider transactions in SGX PHARMACEUTICALS, INC. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 22 2008 | SGXP | SGX PHARMACEUTICAL ... | BAVP, L.P. | 10% Owner | Sell | D | 3.00 | 2,546,747 | 7,640,241 | 0 | 2.5 M to 0 (-100.00 %) |
| Aug 22 2008 | SGXP | SGX PHARMACEUTICAL ... | BOCK LOUIS C | Director | Option Exercise | D | 7.25 | 12,500 | 90,625 | 0 | |
| Aug 22 2008 | SGXP | SGX PHARMACEUTICAL ... | BOCK LOUIS C | Director | Option Exercise | D | 5.03 | 10,000 | 50,300 | 0 | |
| Aug 22 2008 | SGXP | SGX PHARMACEUTICAL ... | BOCK LOUIS C | Director | Option Exercise | D | 1.35 | 10,000 | 13,500 | 0 | |
| Aug 22 2008 | SGXP | SGX PHARMACEUTICAL ... | BOCK LOUIS C | Director | Sell | D | 3.00 | 2,546,747 | 7,640,241 | 0 | 2.5 M to 0 (-100.00 %) |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | TURNER JOSEPH L | Director | Option Exercise | D | 5.00 | 12,500 | 62,500 | 0 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | TURNER JOSEPH L | Director | Option Exercise | D | 1.35 | 10,000 | 13,500 | 0 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | EASTHAM KARIN | Director | Option Exercise | D | 5.03 | 20,000 | 100,600 | 0 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | EASTHAM KARIN | Director | Option Exercise | D | 1.35 | 10,000 | 13,500 | 0 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | EASTHAM KARIN | Director | Sell | D | 3.00 | 12,500 | 37,500 | 0 | 12.5 K to 0 (-100.00 %) |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | HENNEY CHRISTOPHER S | Director | Option Exercise | D | 5.21 | 30,000 | 156,300 | 0 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | HENNEY CHRISTOPHER S | Director | Option Exercise | D | 5.03 | 25,000 | 125,750 | 0 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | HENNEY CHRISTOPHER S | Director | Option Exercise | D | 1.35 | 20,000 | 27,000 | 0 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | HENNEY CHRISTOPHER S | Director | Sell | D | 3.00 | 97,165 | 291,495 | 0 | 97.2 K to 0 (-100.00 %) |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | RUGG TERENCE ANTHONY | CMO & VP, Drug Deve ... | Option Exercise | D | 4.75 | 3,948 | 18,753 | 0 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | RUGG TERENCE ANTHONY | CMO & VP, Drug Deve ... | Option Exercise | D | 3.99 | 18,523 | 73,907 | 0 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | RUGG TERENCE ANTHONY | CMO & VP, Drug Deve ... | Option Exercise | D | 3.63 | 31,741 | 115,220 | 0 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | RUGG TERENCE ANTHONY | CMO & VP, Drug Deve ... | Option Exercise | D | 4.75 | 71,052 | 337,497 | 0 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | RUGG TERENCE ANTHONY | CMO & VP, Drug Deve ... | Option Exercise | D | 3.99 | 7,627 | 30,432 | 0 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | RUGG TERENCE ANTHONY | CMO & VP, Drug Deve ... | Option Exercise | D | 3.63 | 18,259 | 66,280 | 0 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | Reich Siegfried | VP, Drug Discovery | Option Exercise | D | 0.00 | 26,563 | 0 | 0 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | Reich Siegfried | VP, Drug Discovery | Option Exercise | D | 7.66 | 4,446 | 34,056 | 0 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | Reich Siegfried | VP, Drug Discovery | Option Exercise | D | 3.99 | 21,485 | 85,725 | 0 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | Reich Siegfried | VP, Drug Discovery | Option Exercise | D | 3.63 | 45,441 | 164,951 | 0 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | Reich Siegfried | VP, Drug Discovery | Option Exercise | D | 7.66 | 35,554 | 272,344 | 0 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | Reich Siegfried | VP, Drug Discovery | Option Exercise | D | 3.99 | 11,765 | 46,942 | 0 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | Reich Siegfried | VP, Drug Discovery | Option Exercise | D | 3.63 | 34,559 | 125,449 | 0 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | Reich Siegfried | VP, Drug Discovery | Sell | D | 3.00 | 24,223 | 72,669 | 0 | 24.2 K to 0 (-100.00 %) |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | North Annette | General Counsel | Option Exercise | D | 7.66 | 19,538 | 149,661 | 0 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | North Annette | General Counsel | Option Exercise | D | 3.99 | 15,239 | 60,804 | 0 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | North Annette | General Counsel | Option Exercise | D | 3.63 | 25,489 | 92,525 | 0 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | North Annette | General Counsel | Option Exercise | D | 13.44 | 632 | 8,494 | 0 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | North Annette | General Counsel | Option Exercise | D | 13.44 | 948 | 12,741 | 0 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | North Annette | General Counsel | Option Exercise | D | 13.44 | 1,896 | 25,482 | 0 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | North Annette | General Counsel | Option Exercise | D | 13.44 | 632 | 8,494 | 0 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | North Annette | General Counsel | Option Exercise | D | 7.66 | 40,462 | 309,939 | 0 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | North Annette | General Counsel | Option Exercise | D | 3.99 | 18,011 | 71,864 | 0 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | North Annette | General Counsel | Option Exercise | D | 3.96 | 744 | 2,946 | 0 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | North Annette | General Counsel | Option Exercise | D | 3.63 | 24,511 | 88,975 | 0 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | North Annette | General Counsel | Option Exercise | D | 1.00 | 50,000 | 50,000 | 0 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Option Exercise | D | 0.00 | 25,000 | 0 | 0 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Option Exercise | D | 7.66 | 8,821 | 67,569 | 0 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Option Exercise | D | 3.99 | 22,590 | 90,134 | 0 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Option Exercise | D | 3.63 | 34,118 | 123,848 | 0 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Option Exercise | D | 7.66 | 41,179 | 315,431 | 0 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Option Exercise | D | 3.99 | 20,160 | 80,438 | 0 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Option Exercise | D | 3.63 | 15,882 | 57,652 | 0 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Sell | D | 3.00 | 25,005 | 75,015 | 0 | 25 K to 0 (-100.00 %) |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | Burley Stephen | CSO & SVP, Research | Option Exercise | D | 13.44 | 1,777 | 23,883 | 0 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | Burley Stephen | CSO & SVP, Research | Option Exercise | D | 13.44 | 12,351 | 165,997 | 0 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | Burley Stephen | CSO & SVP, Research | Option Exercise | D | 7.66 | 16,914 | 129,561 | 0 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | Burley Stephen | CSO & SVP, Research | Option Exercise | D | 3.99 | 30,281 | 120,821 | 0 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | Burley Stephen | CSO & SVP, Research | Option Exercise | D | 3.63 | 56,373 | 204,634 | 0 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | Burley Stephen | CSO & SVP, Research | Option Exercise | D | 1.58 | 6,175 | 9,757 | 0 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | Burley Stephen | CSO & SVP, Research | Option Exercise | D | 13.44 | 2,529 | 33,990 | 0 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | Burley Stephen | CSO & SVP, Research | Option Exercise | D | 13.44 | 15,174 | 203,939 | 0 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | Burley Stephen | CSO & SVP, Research | Option Exercise | D | 7.66 | 33,086 | 253,439 | 0 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | Burley Stephen | CSO & SVP, Research | Option Exercise | D | 3.99 | 12,469 | 49,751 | 0 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | Burley Stephen | CSO & SVP, Research | Option Exercise | D | 3.96 | 2,003 | 7,932 | 0 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | Burley Stephen | CSO & SVP, Research | Option Exercise | D | 3.63 | 43,627 | 158,366 | 0 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | Burley Stephen | CSO & SVP, Research | Option Exercise | D | 1.00 | 125,000 | 125,000 | 0 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | Burley Stephen | CSO & SVP, Research | Sell | D | 3.00 | 55,731 | 167,193 | 0 | 55.7 K to 0 (-100.00 %) |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | GREY MICHAEL G | President & CEO | Option Exercise | D | 7.66 | 53,772 | 411,894 | 0 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | GREY MICHAEL G | President & CEO | Option Exercise | D | 3.99 | 105,239 | 419,904 | 0 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | GREY MICHAEL G | President & CEO | Option Exercise | D | 3.63 | 97,107 | 352,498 | 0 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | GREY MICHAEL G | President & CEO | Option Exercise | D | 13.44 | 5,058 | 67,980 | 0 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | GREY MICHAEL G | President & CEO | Option Exercise | D | 7.66 | 26,228 | 200,906 | 0 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | GREY MICHAEL G | President & CEO | Option Exercise | D | 3.99 | 27,761 | 110,766 | 0 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | GREY MICHAEL G | President & CEO | Option Exercise | D | 3.96 | 2,383 | 9,437 | 0 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | GREY MICHAEL G | President & CEO | Option Exercise | D | 3.63 | 52,893 | 192,002 | 0 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | GREY MICHAEL G | President & CEO | Option Exercise | D | 1.00 | 263,863 | 263,863 | 0 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | GREY MICHAEL G | President & CEO | Sell | D | 3.00 | 100,000 | 300,000 | 0 | 100 K to 0 (-100.00 %) |
| Aug 18 2008 | SGXP | SGX PHARMACEUTICAL ... | Reich Siegfried | VP, Drug Discovery | Option Exercise | M | 0.00 | 1,562 | 0 | 26,563 | |
| Aug 18 2008 | SGXP | SGX PHARMACEUTICAL ... | Reich Siegfried | VP, Drug Discovery | Sell | S | 2.98 | 781 | 2,327 | 24,223 | 25 K to 24.2 K (-3.12 %) |
| Aug 18 2008 | SGXP | SGX PHARMACEUTICAL ... | Reich Siegfried | VP, Drug Discovery | Buy | M | 0.00 | 1,562 | 0 | 25,004 | 23.4 K to 25 K (+6.66 %) |
| Aug 06 2008 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Option Exercise | M | 0.00 | 1,563 | 0 | 25,000 | |
| Aug 06 2008 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Sell | S | 2.96 | 781 | 2,312 | 25,005 | 25.8 K to 25 K (-3.03 %) |
| Aug 06 2008 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Buy | M | 0.00 | 1,563 | 0 | 25,786 | 24.2 K to 25.8 K (+6.45 %) |
| Jul 16 2008 | SGXP | SGX PHARMACEUTICAL ... | Reich Siegfried | VP, Drug Discovery | Option Exercise | M | 0.00 | 1,563 | 0 | 28,125 | |
| Jul 16 2008 | SGXP | SGX PHARMACEUTICAL ... | Reich Siegfried | VP, Drug Discovery | Sell | S | 3.06 | 100 | 306 | 23,442 | 23.5 K to 23.4 K (-0.42 %) |
| Jul 16 2008 | SGXP | SGX PHARMACEUTICAL ... | Reich Siegfried | VP, Drug Discovery | Sell | S | 3.05 | 681 | 2,077 | 23,542 | 24.2 K to 23.5 K (-2.81 %) |
| Jul 16 2008 | SGXP | SGX PHARMACEUTICAL ... | Reich Siegfried | VP, Drug Discovery | Buy | M | 0.00 | 1,563 | 0 | 24,223 | 22.7 K to 24.2 K (+6.90 %) |
| Jul 07 2008 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Option Exercise | M | 0.00 | 1,562 | 0 | 26,563 | |
| Jul 07 2008 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Sell | S | 1.60 | 781 | 1,250 | 24,223 | 25 K to 24.2 K (-3.12 %) |
| Jul 07 2008 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Buy | M | 0.00 | 1,562 | 0 | 25,004 | 23.4 K to 25 K (+6.66 %) |
| Jun 17 2008 | SGXP | SGX PHARMACEUTICAL ... | Reich Siegfried | VP, Drug Discovery | Option Exercise | M | 0.00 | 1,562 | 0 | 29,688 | |
| Jun 17 2008 | SGXP | SGX PHARMACEUTICAL ... | Reich Siegfried | VP, Drug Discovery | Sell | S | 1.65 | 781 | 1,289 | 22,660 | 23.4 K to 22.7 K (-3.33 %) |
| Jun 17 2008 | SGXP | SGX PHARMACEUTICAL ... | Reich Siegfried | VP, Drug Discovery | Buy | M | 0.00 | 1,562 | 0 | 23,441 | 21.9 K to 23.4 K (+7.14 %) |
| Jun 12 2008 | SGXP | SGX PHARMACEUTICAL ... | BOCK LOUIS C | Director | Option Exercise | A | 1.35 | 10,000 | 13,500 | 10,000 | |
| Jun 11 2008 | SGXP | SGX PHARMACEUTICAL ... | HENNEY CHRISTOPHER S | Director | Option Exercise | A | 1.35 | 20,000 | 27,000 | 20,000 | |
| Jun 11 2008 | SGXP | SGX PHARMACEUTICAL ... | TURNER JOSEPH L | Director | Option Exercise | A | 1.35 | 10,000 | 13,500 | 10,000 | |
| Jun 11 2008 | SGXP | SGX PHARMACEUTICAL ... | EASTHAM KARIN | Director | Option Exercise | A | 1.35 | 10,000 | 13,500 | 10,000 | |
| Jun 06 2008 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Option Exercise | M | 0.00 | 1,563 | 0 | 28,125 | |
| Jun 06 2008 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Sell | S | 1.35 | 781 | 1,054 | 23,442 | 24.2 K to 23.4 K (-3.22 %) |
| Jun 06 2008 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Buy | M | 0.00 | 1,563 | 0 | 24,223 | 22.7 K to 24.2 K (+6.90 %) |
| May 15 2008 | SGXP | SGX PHARMACEUTICAL ... | Reich Siegfried | VP, Drug Discovery | Option Exercise | M | 0.00 | 1,563 | 0 | 31,250 | |
| May 15 2008 | SGXP | SGX PHARMACEUTICAL ... | Reich Siegfried | VP, Drug Discovery | Sell | S | 1.45 | 781 | 1,132 | 21,879 | 22.7 K to 21.9 K (-3.45 %) |
| May 15 2008 | SGXP | SGX PHARMACEUTICAL ... | Reich Siegfried | VP, Drug Discovery | Buy | M | 0.00 | 1,563 | 0 | 22,660 | 21.1 K to 22.7 K (+7.41 %) |
| May 06 2008 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Option Exercise | M | 0.00 | 1,562 | 0 | 29,688 | |
| May 06 2008 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Sell | S | 1.43 | 781 | 1,117 | 22,660 | 23.4 K to 22.7 K (-3.33 %) |
| May 06 2008 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Buy | M | 0.00 | 1,562 | 0 | 23,441 | 21.9 K to 23.4 K (+7.14 %) |
| Apr 16 2008 | SGXP | SGX PHARMACEUTICAL ... | Reich Siegfried | VP, Drug Discovery | Option Exercise | M | 0.00 | 1,562 | 0 | 32,813 | |
| Apr 16 2008 | SGXP | SGX PHARMACEUTICAL ... | Reich Siegfried | VP, Drug Discovery | Sell | S | 1.19 | 481 | 572 | 21,097 | 21.6 K to 21.1 K (-2.23 %) |
| Apr 16 2008 | SGXP | SGX PHARMACEUTICAL ... | Reich Siegfried | VP, Drug Discovery | Sell | S | 1.19 | 300 | 357 | 21,578 | 21.9 K to 21.6 K (-1.37 %) |
| Apr 16 2008 | SGXP | SGX PHARMACEUTICAL ... | Reich Siegfried | VP, Drug Discovery | Buy | M | 0.00 | 1,562 | 0 | 21,878 | 20.3 K to 21.9 K (+7.69 %) |
| Apr 08 2008 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Option Exercise | M | 0.00 | 1,563 | 0 | 31,250 | |
| Apr 08 2008 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Sell | S | 1.30 | 281 | 365 | 21,879 | 22.2 K to 21.9 K (-1.27 %) |
| Apr 08 2008 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Sell | S | 1.34 | 200 | 268 | 22,160 | 22.4 K to 22.2 K (-0.89 %) |
| Apr 08 2008 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Sell | S | 1.36 | 200 | 272 | 22,360 | 22.6 K to 22.4 K (-0.89 %) |
| Apr 08 2008 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Sell | S | 1.37 | 100 | 137 | 22,560 | 22.7 K to 22.6 K (-0.44 %) |
| Apr 08 2008 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Buy | M | 0.00 | 1,563 | 0 | 22,660 | 21.1 K to 22.7 K (+7.41 %) |
| Mar 18 2008 | SGXP | SGX PHARMACEUTICAL ... | Reich Siegfried | VP, Drug Discovery | Option Exercise | M | 0.00 | 1,563 | 0 | 34,375 | |
| Mar 18 2008 | SGXP | SGX PHARMACEUTICAL ... | Reich Siegfried | VP, Drug Discovery | Sell | S | 4.01 | 781 | 3,132 | 20,316 | 21.1 K to 20.3 K (-3.70 %) |
| Mar 18 2008 | SGXP | SGX PHARMACEUTICAL ... | Reich Siegfried | VP, Drug Discovery | Buy | M | 0.00 | 1,563 | 0 | 21,097 | 19.5 K to 21.1 K (+8.00 %) |
| Mar 05 2008 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Option Exercise | M | 0.00 | 1,562 | 0 | 32,813 | |
| Mar 05 2008 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Sell | S | 4.05 | 781 | 3,163 | 21,097 | 21.9 K to 21.1 K (-3.57 %) |
| Mar 05 2008 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Buy | M | 0.00 | 1,562 | 0 | 21,878 | 20.3 K to 21.9 K (+7.69 %) |
| Feb 25 2008 | SGXP | SGX PHARMACEUTICAL ... | RUGG TERENCE ANTHONY | CMO & VP, Drug Deve ... | Option Exercise | A | 3.99 | 18,523 | 73,907 | 18,523 | |
| Feb 25 2008 | SGXP | SGX PHARMACEUTICAL ... | RUGG TERENCE ANTHONY | CMO & VP, Drug Deve ... | Option Exercise | A | 3.99 | 7,627 | 30,432 | 7,627 | |
| Feb 25 2008 | SGXP | SGX PHARMACEUTICAL ... | Reich Siegfried | VP, Drug Discovery | Option Exercise | A | 3.99 | 21,485 | 85,725 | 21,485 | |
| Feb 25 2008 | SGXP | SGX PHARMACEUTICAL ... | Reich Siegfried | VP, Drug Discovery | Option Exercise | A | 3.99 | 11,765 | 46,942 | 11,765 | |
| Feb 25 2008 | SGXP | SGX PHARMACEUTICAL ... | North Annette | General Counsel | Option Exercise | A | 3.99 | 15,239 | 60,804 | 15,239 | |
| Feb 25 2008 | SGXP | SGX PHARMACEUTICAL ... | North Annette | General Counsel | Option Exercise | A | 3.99 | 18,011 | 71,864 | 18,011 | |
| Feb 25 2008 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Option Exercise | A | 3.99 | 22,590 | 90,134 | 22,590 | |
| Feb 25 2008 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Option Exercise | A | 3.99 | 20,160 | 80,438 | 20,160 | |
| Feb 25 2008 | SGXP | SGX PHARMACEUTICAL ... | Burley Stephen | CSO & SVP, Research | Option Exercise | A | 3.99 | 30,281 | 120,821 | 30,281 | |
| Feb 25 2008 | SGXP | SGX PHARMACEUTICAL ... | Burley Stephen | CSO & SVP, Research | Option Exercise | A | 3.99 | 12,469 | 49,751 | 12,469 | |
| Feb 25 2008 | SGXP | SGX PHARMACEUTICAL ... | GREY MICHAEL G | President & CEO | Option Exercise | A | 3.99 | 105,239 | 419,904 | 105,239 | |
| Feb 25 2008 | SGXP | SGX PHARMACEUTICAL ... | GREY MICHAEL G | President & CEO | Option Exercise | A | 3.99 | 27,761 | 110,766 | 27,761 | |
| Feb 19 2008 | SGXP | SGX PHARMACEUTICAL ... | Reich Siegfried | VP, Drug Discovery | Option Exercise | M | 0.00 | 1,562 | 0 | 35,938 | |
| Feb 19 2008 | SGXP | SGX PHARMACEUTICAL ... | Reich Siegfried | VP, Drug Discovery | Sell | S | 4.05 | 781 | 3,163 | 19,534 | 20.3 K to 19.5 K (-3.84 %) |
| Feb 19 2008 | SGXP | SGX PHARMACEUTICAL ... | Reich Siegfried | VP, Drug Discovery | Buy | M | 0.00 | 1,562 | 0 | 20,315 | 18.8 K to 20.3 K (+8.33 %) |
| Feb 05 2008 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Option Exercise | M | 0.00 | 1,563 | 0 | 34,375 | |
| Feb 05 2008 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Sell | S | 4.40 | 781 | 3,436 | 20,316 | 21.1 K to 20.3 K (-3.70 %) |
| Feb 05 2008 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Buy | M | 0.00 | 1,563 | 0 | 21,097 | 19.5 K to 21.1 K (+8.00 %) |
| Jan 16 2008 | SGXP | SGX PHARMACEUTICAL ... | Reich Siegfried | VP, Drug Discovery | Option Exercise | M | 0.00 | 1,563 | 0 | 37,500 | |
| Jan 16 2008 | SGXP | SGX PHARMACEUTICAL ... | Reich Siegfried | VP, Drug Discovery | Sell | S | 4.44 | 781 | 3,468 | 18,753 | 19.5 K to 18.8 K (-4.00 %) |
| Jan 16 2008 | SGXP | SGX PHARMACEUTICAL ... | Reich Siegfried | VP, Drug Discovery | Buy | M | 0.00 | 1,563 | 0 | 19,534 | 18 K to 19.5 K (+8.70 %) |
| Jan 07 2008 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Option Exercise | M | 0.00 | 1,562 | 0 | 35,938 | |
| Jan 07 2008 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Sell | S | 5.15 | 781 | 4,022 | 19,534 | 20.3 K to 19.5 K (-3.84 %) |
| Jan 07 2008 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Buy | M | 0.00 | 1,562 | 0 | 20,315 | 18.8 K to 20.3 K (+8.33 %) |
| Dec 18 2007 | SGXP | SGX PHARMACEUTICAL ... | Reich Siegfried | VP, Drug Discovery | Option Exercise | M | 0.00 | 1,562 | 0 | 39,063 | |
| Dec 18 2007 | SGXP | SGX PHARMACEUTICAL ... | Reich Siegfried | VP, Drug Discovery | Sell | S | 4.75 | 781 | 3,710 | 17,971 | 18.8 K to 18 K (-4.16 %) |
| Dec 18 2007 | SGXP | SGX PHARMACEUTICAL ... | Reich Siegfried | VP, Drug Discovery | Buy | M | 0.00 | 1,562 | 0 | 18,752 | 17.2 K to 18.8 K (+9.09 %) |
| Dec 17 2007 | SGXP | SGX PHARMACEUTICAL ... | TURNER JOSEPH L | Director | Option Exercise | A | 4.87 | 12,500 | 60,875 | 12,500 | |
| Dec 05 2007 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Option Exercise | M | 0.00 | 1,563 | 0 | 37,500 | |
| Dec 05 2007 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Sell | S | 4.85 | 781 | 3,788 | 18,753 | 19.5 K to 18.8 K (-4.00 %) |
| Dec 05 2007 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Buy | M | 0.00 | 1,563 | 0 | 19,534 | 18 K to 19.5 K (+8.70 %) |
| Nov 16 2007 | SGXP | SGX PHARMACEUTICAL ... | Reich Siegfried | VP, Drug Discovery | Option Exercise | M | 0.00 | 1,563 | 0 | 40,625 | |
| Nov 16 2007 | SGXP | SGX PHARMACEUTICAL ... | Reich Siegfried | VP, Drug Discovery | Sell | S | 5.10 | 781 | 3,983 | 17,190 | 18 K to 17.2 K (-4.35 %) |